Sanofi says myelofibrosis treatment study positive
PARIS (Reuters) - French drugmaker Sanofi said a late-stage Phase III trial of a drug designed to treat myelofibrosis led to positive results.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/OQmxz2-QYPA/story01.htm
No comments:
Post a Comment